Abstract:Since the World Health Assembly established the Global Polio Eradication Initiative (GPEI) in 1988, two of the three wild poliovirus (WPV) serotypes (types 2 and 3) have been eradicated, and global WPV cases have decreased by more than 99.9%. Afghanistan and Pakistan remain the only countries where indigenous WPV type 1 (WPV1) transmission has not been interrupted. This report summarizes progress toward global polio eradication during January 1, 2021-March 31, 2023, and updates previous reports (1,2). In 2022, Afghanistan and Pakistan reported 22 WPV1 cases, compared with five in 2021; as of May 5, 2023, a single WPV1 case was reported in Pakistan in 2023. A WPV1 case was reported on the African continent for the first time since 2016, when officials in Malawi confirmed a WPV1 case in a child with paralysis onset in November 2021; neighboring Mozambique subsequently reported eight genetically linked cases. Outbreaks of polio caused by circulating vaccine-derived polioviruses (cVDPVs) can occur when oral poliovirus vaccine (OPV) strains circulate for a prolonged time in underimmunized populations, allowing reversion to neurovirulence (3). A total of 859 cVDPV cases occurred during 2022, an increase of 23% from 698 cases in 2021. cVDPVs were detected in areas where poliovirus transmission had long been eliminated (including in Canada, Israel, the United Kingdom, and the United States). In addition, cocirculation of multiple poliovirus types occurred in multiple countries globally (including Democratic Republic of the Congo [DRC], Israel, Malawi, Mozambique, Republic of the Congo, and Yemen). The 2022-2026 GPEI strategic plan targeted the goal of detecting the last cases of WPV1 and cVDPV in 2023 (4). The current global epidemiology of poliovirus transmission makes the likelihood of meeting this target date unlikely. The detections of poliovirus (WPV1 and cVDPVs) in areas where it had been previously eliminated underscore the threat of continued poliovirus spread to any area where there is insufficient vaccination to poliovirus (3). Mass vaccination and surveillance should be further enhanced in areas of transmission to interrupt poliovirus transmission and to end the global threat of paralytic polio in children.

Progress Toward Poliomyelitis Eradication — Worldwide, January 2022–December 2023

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2023–September 2024

Progress Toward Poliomyelitis Eradication - Worldwide, January 2021-March 2023

Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023

Progress Toward Poliomyelitis Eradication - Pakistan, January 2021-July 2022

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2023–June 2024

Polio Epidemiology: Strategies and Challenges for Polio Eradication Post the COVID-19 Pandemic

Progress toward polio eradication--Somalia, 1998-2013

Polio eradication in India: current status

Eradication of poliomyelitis in countries affected by conflict

Reported Polio cases in Pakistan during 2019

Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs)

Eradication and Current Status of Poliomyelitis in Pakistan: Ground Realities

Antiviral Development for the Polio Endgame: Current Progress and Future Directions

Polio Amidst COVID-19 in Pakistan: What Are the Efforts Being Made and Challenges at Hand?

Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022

Population Immunity and Polio Eradication

Threat of resurgence or hope for global eradication of poliovirus?

Polio outbreak in Pakistan: urgent need for strengthened localized eradication strategies

Global polio eradication; can we replicate the smallpox success story?

Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan